Larry R. Engelking
- Equine top 2%
- Small Animals top 5%
- Hepatology top 10%
- Liver Disease and Transplantation 4
- Pharmacology top 10%
- Drug-Induced Hepatotoxicity and Protection 3
-
- Drug Transport and Resistance Mechanisms 9
-
- Liver Disease Diagnosis and Treatment 10
-
- Metabolism and Genetic Disorders 5
-
- Neonatal Health and Biochemistry 4
-
- Neuropeptides and Animal Physiology 4
-
- Aldose Reductase and Taurine 3
- Co-authors
- M. Sawkat AnwerS. GrüneRonald GronwallJeanne LöfstedtM. S. AnwerSawkat M. AnwerPiotr ZimniakRoger Lester
- Cited by
- EquineSmall AnimalsHepatology
- Journals
- Journal of Biological Chemistry (1 paper)Hepatology (1 paper)Journal of Pharmacology and Experimental Therapeutics (1 paper)
- Partner nations
- United StatesCyprusCzechia
In The Last Decade
Larry R. Engelking
34 papers receiving 503 citations
Peers
Comparison fields: 5 of 81
- Equine 78
- Small Animals 86
- Hepatology 60
- Pharmacology 64
- Oncology 189
Countries citing papers authored by Larry R. Engelking
This map shows the geographic impact of Larry R. Engelking's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Larry R. Engelking with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Larry R. Engelking more than expected).
Fields of papers citing papers by Larry R. Engelking
This network shows the impact of papers produced by Larry R. Engelking. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Larry R. Engelking. The network helps show where Larry R. Engelking may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Larry R. Engelking, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1998 | 9 | |
| 2 | 1998 | 11 | |
| 3 | 1998 | 17 | |
| 4 | 1997 | 8 | |
| 5 | 1997 | 2 | |
| 6 | 1994 | 3 | |
| 7 | 1993 | 12 | |
| 8 | Equine fasting hyperbilirubinemia. | 1993 | 15 |
| 9 | Evaluation of equine bilirubin and bile acid metabolism | 1989 | 13 |
| 10 | 1989 | 4 | |
| 11 | Disorders of bilirubin metabolism in small animal species | 1988 | 1 |
| 12 | 1988 | 12 | |
| 13 | 1988 | 8 | |
| 14 | 1987 | 9 | |
| 15 | 1985 | 11 | |
| 16 | 1985 | 7 | |
| 17 | 1985 | 13 | |
| 18 | 1982 | 10 | |
| 19 | 1980 | 10 | |
| 20 | 1980 | 9 |
About Larry R. Engelking
Larry R. Engelking is a scholar working on Clinical Biochemistry, Equine and Behavioral Neuroscience, having authored 34 papers that have together received 518 indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (10 papers), Drug Transport and Resistance Mechanisms (9 papers), Metabolism and Genetic Disorders (5 papers), Neonatal Health and Biochemistry (4 papers), Liver Disease and Transplantation (4 papers), Neuropeptides and Animal Physiology (4 papers), Aldose Reductase and Taurine (3 papers) and Drug-Induced Hepatotoxicity and Protection (3 papers). The work is most often cited by research in Equine (78 citations), Small Animals (86 citations) and Hepatology (60 citations). Larry R. Engelking has collaborated with scholars based in United States, Cyprus and Czechia. Frequent co-authors include M. Sawkat Anwer, S. Grüne, Ronald Gronwall, Jeanne Löfstedt, M. S. Anwer, Sawkat M. Anwer, Piotr Zimniak, Roger Lester, Gershwin T. Blyden and David J. Greenblatt. Their work appears in journals such as Journal of Biological Chemistry, Hepatology and Journal of Pharmacology and Experimental Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.